Oregon Drug Discovery Symposium

Connect with the drug discovery community!

Welcome to the first Oregon Drug Discovery Symposium (ODDS). This event offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate a day of exciting talks and discussions, including a poster session. We look forward to welcoming you to 博彩网站 for ODDS 2025.
— Sanjay V. Malhotra, Ph.D., Director, 博彩网站 Center for Experimental Therapeutics
Poster Presenter List
April 9, 2025
8 a.m.-6 p.m.
Knight Cancer Research Building (and Webex)
2720 S. Moody Ave.
Portland, OR 97201
Contact
Email CET@ohsu.edu
Participants

Nabil Alkayed, M.D., Ph.D.
James Metcalfe Chair of Cardiovascular Research
Professor, Anesthesiology & Perioperative Medicine
Director of Research, Knight Cardiovascular Institute

Travis Cook, M.S., M.B.A., CLP
Senior Director, Technology Transfer, 博彩网站

Lisa M. Coussens, Ph.D., FAACR, FAIO
Deputy Director, Basic & Translational Research, 博彩网站 Knight Cancer Institute

Victor DeFillipis, Ph.D.
Associate Professor, VGTI-Vaccine and Gene Therapy Institute, 博彩网站
Assistant Professor, Oregon National Primate Research Center

Leah Frye, Ph.D.
Founder, LLFrye Consulting,
Senior Advisor, Health Tech Innovations, Inc.

Jack Gomer
Investor, Multicare Health System
Seattle, WA

Susan Hayflick, M.D., Ph.D.
Professor of Molecular and Medical Genetics, Pediatrics and Neurology, School of Medicine, 博彩网站
Chair, Molecular and Medical Genetics, School of Medicine, 博彩网站

Mary M. Heinricher, Ph.D.
Senior Associate Dean
博彩网站 School of Medicine

Joe Horsman, Ph.D.
Investor, Madrona

Shula Jaron, Ph.D.
Chair, Oregon Bio Women
Entrepreneur-in-Residence, Oregon Nanoscience and Microtechnologies Institute

Shannon McWeeney, Ph.D.
Professor, Division of Oncological Sciences, 博彩网站 School of Medicine
Chief Data Officer, 博彩网站 Knight Cancer Institute

Gordon Mills, M.D., Ph.D.
Wayne and Julie Drinkward Endowed Chair in Precision Oncology
Director of Precision Oncology, 博彩网站 Knight Cancer Institute

Kelly Monk, Ph.D.
Professor and Co-Director, Vollum Institute, 博彩网站
Program Director, Neuroscience Graduate Program, 博彩网站 School of Medicine

Lee Neilson, M.D.
Assistant Professor, Department of Neurology, 博彩网站
Staff Neurologist, Portland VA Medical Center

Angelica Parente, Ph.D.
VP of Platform Development, Savanna Bio

Michael Phillips
Partner, Davis Wright Tremaine LLP

Rajat Roy
CEO and Co-Founder, PathomIQ Inc.

Shilpa Sambashivan, Ph.D.
CEO, Nura Bio

Nathan R. Selden, M.D., Ph.D.
Dean, 博彩网站 School of Medicine

H. Michael Shepard, Ph.D.
Adjunct Professor, Department of Biology, Indiana University
Lasker Award (2019)

Steve Stadum, J.D.
Interim President, 博彩网站

Craig Stolarczy
Cofounder and CEO, SynPlexity

Ronan Swords, M.D., Ph.D.
Professor of Medicine, Division of Hematology/Medical Oncology, 博彩网站

David K. Thomas, M.D.
Director, Cachexia Discovery and Therapeutic Development, Broad Institute of MIT & Harvard
Founder, Cerise Therapeutics
Learn more
In person
In-person registration includes breakfast, lunch, a networking reception and access to the virtual livestream. Fees:
- Academic: $30
- Non-academic: $75
Virtual:
- Virtual-only attendance is free but requires registration.
You will receive an email from EventBrite containing your ticket and registration information. Please save this email for future reference and to show at registration. If you are on the waitlist or register to attend virtually, you will receive an email but will not receive a ticket. If you have questions about your registration, please email CET@ohsu.edu.
Researchers, scientists, and industry professionals are invited to showcase their work and network at the poster session. Poster presenter registration (which includes one attendee registration) is available here.
The event will be held at the Knight Cancer Research Building located on Portland's South Waterfront. Click below to view a map, parking, public transportation and driving directions.
Knight Cancer Research Building
2720 S. Moody Ave.
Portland, OR 97201

Sanjay Malhotra, Ph.D.
Professor of Cell, Developmental and Cancer Biology, 博彩网站 School of Medicine
Endowed Chair, Cancer Research, Cell, Developmental and Cancer Biology, 博彩网站 School of Medicine
Director, 博彩网站 Center for Experimental Therapeutics

Shivaani Kummar, M.D.
Margaret and Lester DeArmond University Chair of Molecular Oncology, Medicine, Division of Hematology/Medical Oncology, 博彩网站 School of Medicine
Co-Director, Center for Experimental Therapeutics, 博彩网站 Knight Cancer Institute
Co-Deputy Director, 博彩网站 Knight Cancer Institute

Marc Freeman, Ph.D.
Director, Vollum Institute, 博彩网站

Jee Min Lee, M.S.
Graduate Student, Center for Experimental Therapeutics, 博彩网站

Annah Rolig, Ph.D.
Senior Scientist, Center for Experimental Therapeutics, 博彩网站

Denise Hopkins
Program Administrator, Center for Experimental Therapeutics, 博彩网站
Sponsors
Interested in sponsoring ODDS 2025? Email CET@ohsu.edu.